Ozempic’s Success Is Bad News for Rivals

Airlines are cutting uneconomic routes, revising forecasts, and building in buffers, effectively managing around volatility rather than eliminating it. That’s creating a downstream behavioral shift. Travelers, particularly at the premium end, are no longer optimizing for price or ... Show More

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.Jared Kushner, envoy for President Donald Trump, sends WhatsApp messages to royals across the Persian Gulf and has participated in investment meetings ... Show More

The people, companies and trends shaping the global economy. Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. Hosts Carol Massar and Tim Stenovec speak with Haley Sacks: Mrs. Dow Jones and author of 'Future Rich Person'. They discuss her work, personal financ ... Show More

Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ... Show More

The FDA has approved a new drug for Alzheimer's. But a lot of experts are skeptical about whether the drug works. Rhitu Chatterjee talks with science correspondent Jon Hamilton about the controversial drug aducanumab and why the U.S. Food and Drug Administration approved it. For ... Show More

<p>As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is&nbsp;being used in Italy.&nbsp;</p><br><p><strong>Guests:&nbsp;</stro ... Show More

<p>In the first of two episodes this week, we're taking a deep dive into the pharmaceutical industry. </p><p>How much does the medication you take actually cost? What if a company came along and bought the rights to a particular drug and started charging double, triple, or even 1 ... Show More

For many years, pharmaceutical companies have tried and failed to find a treatment to slow symptoms of ALS–the debilitating, fatal illness also known as Lou Gehrig’s Disease. A potentially promising new drug from Biogen may offer some relief to those afflicted with an uncommon an ... Show More

The US has issued a new indictment against Wikileaks founder Julian Assange. Hospitals in the US may soon no longer be able to keep their prices secret from patients. Industrial giant Honeywell claims they've made the world's most powerful quantum computer, but experts remain ske ... Show More